Marietta Landgraf

Marietta Landgraf is a Research Scientist specializing in Antibody Discovery and Protein Engineering at CSL since January 2020, where expertise includes isolating and engineering therapeutic candidates and conducting molecular assays. Previously, Marietta served as a Postgraduate Researcher at Queensland University of Technology, leading in vivo studies on targeted nanoparticle treatments for cancer bone metastasis and publishing multiple research papers. Academic credentials include a PhD in Biomedical Sciences from QUT and degrees in Molecular Biotechnology from the Technical University of Munich. Marietta has also participated in industry mentoring programs and has experience in various research roles, including functionalizing therapeutic proteins and conducting immunohistochemistry.